MediWound Ltd. (MDWD)
12.87
-0.28
(-2.13%)
USD |
NASDAQ |
Oct 07, 16:00
12.87
0.00 (0.00%)
After-Hours: 19:47
MediWound Net Income (Quarterly) : -7.392M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -7.392M |
| March 31, 2026 | -2.952M |
| December 31, 2025 | -7.183M |
| September 30, 2025 | -2.652M |
| June 30, 2025 | -13.32M |
| March 31, 2025 | -0.726M |
| December 31, 2024 | -3.908M |
| September 30, 2024 | -10.28M |
| June 30, 2024 | -6.305M |
| March 31, 2024 | -9.729M |
| December 31, 2023 | -1.743M |
| September 30, 2023 | -2.196M |
| June 30, 2023 | 0.916M |
| March 31, 2023 | -3.693M |
| December 31, 2022 | -7.457M |
| September 30, 2022 | -4.199M |
| June 30, 2022 | -4.354M |
| March 31, 2022 | -3.589M |
| December 31, 2021 | -4.16M |
| September 30, 2021 | -3.345M |
| June 30, 2021 | -3.195M |
| March 31, 2021 | -2.851M |
| December 31, 2020 | -1.729M |
| September 30, 2020 | -1.99M |
| June 30, 2020 | -3.096M |
| Date | Value |
|---|---|
| March 31, 2020 | -2.461M |
| December 31, 2019 | -3.526M |
| September 30, 2019 | -2.964M |
| June 30, 2019 | 12.72M |
| March 31, 2019 | -4.16M |
| December 31, 2018 | 5.995M |
| September 30, 2018 | -2.944M |
| June 30, 2018 | -4.165M |
| March 31, 2018 | -4.551M |
| December 31, 2017 | -2.253M |
| September 30, 2017 | -3.504M |
| June 30, 2017 | -4.462M |
| March 31, 2017 | -4.314M |
| December 31, 2016 | -1.886M |
| September 30, 2016 | -5.711M |
| June 30, 2016 | -7.511M |
| March 31, 2016 | -3.774M |
| December 31, 2015 | -7.78M |
| September 30, 2015 | -3.766M |
| June 30, 2015 | -4.132M |
| March 31, 2015 | -5.993M |
| December 31, 2014 | -7.094M |
| September 30, 2014 | -5.017M |
| June 30, 2014 | -6.029M |
| March 31, 2014 | -0.735M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Teva Pharmaceutical Industries Ltd. | -585.89M |
| RedHill Biopharma Ltd. | -- |
| Purple Biotech Ltd. | 0.4486M |
| Sol-Gel Technologies Ltd. | -3.681M |
| PolyPid Ltd. | -7.849M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 3.092M |
| Total Expenses (Quarterly) | 10.48M |
| EPS Diluted (Quarterly) | -0.5737 |
| Enterprise Value | 143.97M |
| Gross Profit Margin (Quarterly) | 10.90% |
| Profit Margin (Quarterly) | -239.1% |
| Earnings Yield | -12.46% |
| Normalized Earnings Yield | -12.46 |